Eagle Pharmaceuticals shares owned by AQR Capital Management
Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by AQR Capital Management
from 13F filings
Historical chart of AQR Capital Management investment in Eagle Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Eagle Pharmaceuticals held by AQR Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eagle Pharmaceuticals by AQR Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $2.6M | 494k | 5.23 |
| 2023-09-30 | $4.5M | 283k | 15.77 |
| 2023-06-30 | $7.2M | 368k | 19.44 |
| 2023-03-31 | $7.5M | 265k | 28.37 |
| 2022-12-31 | $4.0M | 135k | 29.23 |
| 2022-09-30 | $2.5M | 96k | 26.42 |
| 2022-06-30 | $2.3M | 51k | 44.43 |
| 2022-03-31 | $2.1M | 42k | 49.50 |
| 2021-12-31 | $2.4M | 47k | 50.93 |
| 2021-09-30 | $2.6M | 47k | 55.78 |
| 2021-06-30 | $2.4M | 56k | 42.80 |
| 2021-03-31 | $2.6M | 61k | 41.74 |
| 2020-12-31 | $2.1M | 45k | 46.57 |
| 2020-09-30 | $2.8M | 66k | 42.47 |
| 2020-06-30 | $4.4M | 92k | 47.98 |
| 2020-03-31 | $6.7M | 145k | 46.00 |
| 2019-12-31 | $7.7M | 128k | 60.08 |
| 2019-09-30 | $6.4M | 113k | 56.57 |
| 2019-06-30 | $6.4M | 114k | 55.68 |
| 2019-03-31 | $5.5M | 108k | 50.49 |
| 2018-12-31 | $3.9M | 97k | 40.29 |
| 2018-09-30 | $4.7M | 68k | 69.33 |
| 2018-06-30 | $3.6M | 48k | 75.66 |
| 2018-03-31 | $3.4M | 64k | 52.69 |
| 2017-12-31 | $8.5M | 159k | 53.42 |
| 2017-09-30 | $12M | 201k | 59.64 |
| 2017-06-30 | $8.6M | 110k | 78.67 |
| 2017-03-31 | $2.9M | 35k | 82.93 |
| 2016-12-31 | $1.6M | 20k | 79.33 |
| 2016-09-30 | $1.4M | 20k | 69.99 |
| 2016-06-30 | $1.2M | 31k | 38.80 |
| 2016-03-31 | $1.4M | 36k | 40.51 |
| 2015-12-31 | $2.4M | 28k | 88.62 |
| 2015-09-30 | $3.3M | 45k | 74.03 |
| 2015-06-30 | $2.2M | 27k | 80.86 |
| 2015-03-31 | $356k | 8.5k | 41.88 |
More positions owned by AQR Capital Management
Cigna Corp (CI)
View all positions for AQR Capital Management